Featured in CardioExchange: Controlling Resistant Hypertension by Renal Denervation — Physician’s First Watch

Medical News |
January 25, 2013

Featured in CardioExchange: Controlling Resistant Hypertension by Renal Denervation

By The CardioExchange Editors

Renal denervation as a treatment for drug-resistant hypertension — already approved in many parts of the world and potentially headed for approval here in the U.S. — remains a controversial topic with a lot of uncertainty. To shed some light on the issue, CardioExchange's Dr. John Ryan posed some questions to Dr. Murray David Esler, a pioneer in the field.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
Last load event
Format: 2016-08-27 13:04:08
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.